BCM
GILD icon

Brasada Capital Management’s Gilead Sciences GILD Stock Holding History

Brasada Capital Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-148
Closed -$11K – 315
2018
Q3 		$11K Buy
+148
New +$11.2K ﹤0.01% 279

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Brasada Capital Management's GILD Position: Q4 2018 in Review

Brasada Capital Management sold out of Gilead Sciences (GILD) in Q4 2018, closing a stake of 148 shares — an estimated $11K sold.

Brasada Capital Management first reported a position in GILD in Q3 2018 and held it in 1 quarter. The position peaked at $11K in Q3 2018. 1,496 funds tracked by Wall St. Rank hold GILD as of Q4 2018.

  • Brasada Capital Management reported no remaining Gilead Sciences position as of Q4 2018 after selling out during the quarter.
  • Brasada Capital Management sold 148 Gilead Sciences shares in Q4 2018, an estimated $11K.
  • Brasada Capital Management first reported a position in Gilead Sciences in Q3 2018 and held it in 1 quarter.
  • Brasada Capital Management's Gilead Sciences position peaked at $11K in Q3 2018.
  • 1,496 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2018.

Based on Brasada Capital Management's 13F filing for Q4 2018, filed 5 Feb 2019.